EP Patent

EP1364650A1 — Medicinal composition

Assigned to Teijin Ltd · Expires 2003-11-26 · 22y expired

What this patent protects

A pharmaceutical composition comprising a biphenylamidine derivative, particles for nucleus and a binder. Specifically, a pharmaceutical composition obtained by coating the particles for nucleus with the biphenylamidine derivative and the binder.

USPTO Abstract

A pharmaceutical composition comprising a biphenylamidine derivative, particles for nucleus and a binder. Specifically, a pharmaceutical composition obtained by coating the particles for nucleus with the biphenylamidine derivative and the binder.

Drugs covered by this patent

Patent Metadata

Patent number
EP1364650A1
Jurisdiction
EP
Classification
—
Expires
2003-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Teijin Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.